Jim Simons Merck & Co., Inc. Transaction History

Renaissance Technologies LLC

$63.4 Billion
Q4 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Merck & Co., Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 1,381,636 shares of MRK stock, worth $124 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

1,381,636

Previous 1,085,878 27.24%

Holding current value

$124 Million

Previous $123 Million 11.46%

% of portfolio

0.22%

Previous 0.2%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$96.31 - $114.76 $28.5 Million - $33.9 Million	295,758 Added 27.24%	1,381,636 $137 Million
Q3 2024 Nov 13, 2024	BUY	$111.15 - $128.97 $120 Million - $139 Million	1,080,963 Added 21993.14%	1,085,878 $123 Million
Q2 2024 Aug 09, 2024	SELL	$123.8 - $132.96 $24.2 Million - $26 Million	-195,287 Reduced 97.54%	4,915 $608,000
Q1 2024 May 13, 2024	BUY	$113.24 - $131.95 $9.1 Million - $10.6 Million	80,378 Added 67.08%	200,202 $26.4 Million
Q4 2023 Feb 13, 2024	SELL	$100.18 - $109.02 $24.8 Million - $27 Million	-247,819 Reduced 67.41%	119,824 $13.1 Million
Q3 2023 Nov 14, 2023	SELL	$102.95 - $114.33 $61.8 Million - $68.7 Million	-600,509 Reduced 62.03%	367,643 $37.8 Million
Q2 2023 Aug 11, 2023	SELL	$108.61 - $118.38 $183 Million - $199 Million	-1,681,107 Reduced 63.46%	968,152 $112 Million
Q1 2023 May 12, 2023	BUY	$102.94 - $114.86 $99.8 Million - $111 Million	969,157 Added 57.68%	2,649,259 $282 Million
Q4 2022 Feb 13, 2023	SELL	$87.44 - $112.11 $252 Million - $323 Million	-2,883,132 Reduced 63.18%	1,680,102 $186 Million
Q3 2022 Nov 14, 2022	SELL	$84.53 - $94.96 $186 Million - $209 Million	-2,200,700 Reduced 32.54%	4,563,234 $393 Million
Q2 2022 Aug 12, 2022	BUY	$83.49 - $94.64 $139 Million - $158 Million	1,664,600 Added 32.64%	6,763,934 $617 Million
Q1 2022 May 13, 2022	BUY	$73.51 - $82.4 $361 Million - $405 Million	4,915,334 Added 2671.38%	5,099,334 $418 Million
Q4 2021 Feb 11, 2022	SELL	$72.28 - $90.54 $95 Million - $119 Million	-1,315,000 Reduced 87.73%	184,000 $14.1 Million
Q3 2021 Nov 12, 2021	BUY	$71.68 - $78.83 $53.1 Million - $58.3 Million	740,200 Added 97.55%	1,499,000 $113 Million
Q2 2021 Aug 13, 2021	BUY	$70.31 - $77.77 $17.7 Million - $19.5 Million	251,366 Added 49.54%	758,800 $59 Million
Q1 2021 May 13, 2021	BUY	$68.86 - $81.11 $33 Million - $38.9 Million	479,219 Added 1698.45%	507,434 $39.1 Million
Q4 2020 Feb 10, 2021	SELL	$71.77 - $79.65 $85.8 Million - $95.2 Million	-1,195,524 Reduced 97.69%	28,215 $2.31 Million
Q3 2020 Nov 13, 2020	SELL	$73.18 - $82.95 $184 Million - $209 Million	-2,516,690 Reduced 67.28%	1,223,739 $102 Million
Q2 2020 Aug 13, 2020	SELL	$70.42 - $80.13 $222 Million - $253 Million	-3,151,941 Reduced 45.73%	3,740,429 $289 Million
Q1 2020 May 14, 2020	BUY	$63.36 - $87.82 $77.2 Million - $107 Million	1,219,127 Added 21.49%	6,892,370 $530 Million
Q4 2019 Feb 13, 2020	BUY	$77.58 - $87.54 $126 Million - $142 Million	1,625,830 Added 40.17%	5,673,243 $516 Million
Q3 2019 Nov 13, 2019	BUY	$76.08 - $82.93 $208 Million - $226 Million	2,730,013 Added 207.23%	4,047,413 $341 Million
Q2 2019 Aug 12, 2019	BUY	$69.84 - $81.59 $92 Million - $107 Million	1,317,400 New	1,317,400 $110 Million

Others Institutions Holding MRK

# of Institutions

3,954

Shares Held

1.86B

Call Options Held

16M

Put Options Held

15M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $227B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account